Evolving Practice Standards and Disease Progression Beyond Frontline Therapy for Patients with DLBCL
January 16th 2024A brief discussion on evolving practice standards and clinical perspectives that help to inform selection of best therapy for patients with DLBCL that progress beyond initial therapy.
Read More
Dr. Patel on Ibrutinib in Real-World Setting Versus Clinical Trials
February 13th 2019Krish Patel, MD, medical oncologist, Swedish Cancer Institute, discusses a study looking at real-world benefit of BTK inhibitors versus what is seen in clinical trials for patients with mantle cell lymphoma.
Read More